Public annual accounts

GINOVIV financials

Name: GINOVIV financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for GINOVIV, with comparable measures and links to available source documents.

Company overview

Registry number

0477945229

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for GINOVIV

2025 versus 2024

Operating line: €26,524
Total assets: €183,533
Equity: €181,728

Equity ratio +99%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202530 Jun 2025	€26,524	-	€183,533	€181,728	-
202430 Jun 2024	€14,527	-	€165,735	€162,601	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report